Case Summary:

We are delighted to be part of this success story, as our client, a postdoctoral scholar of Indian origin working in the United States in biotechnology, successfully secured her I-140 NIW (National Interest Waiver) petition approval. Having completed her postdoctoral research in the USA, she sought the assistance of the North America Immigration Law Group to file her NIW petition. At the time of hiring us, her work and research had:

• 267 citations from five peer-reviewed journal articles (two of them first-authored) and nine technical reports (all of them first-authored), which she published in the top journals and conferences in her field, reflecting her peer’s recognition of the value of this research. Her extensive knowledge and proficiency in cellular molecular biology, gene expression, biochemistry, immunology, microbiology, and metagenomics have led to her frequent invitations to perform peer reviews for prestigious scientific journals. So far, she has completed at least nine reviews. Since only the most respected researchers are selected to assess the work of their colleagues in such prominent venues, it’s evident that she is regarded as an expert in her chosen field.

Our incredibly adapting team members helped her complete the I-140 process by accumulating the most essential information to put in her petition packet:

• We confirmed that her research on the interplay of vital strains, viral load, co-infection, and host and microbiome responses in COVID-19 patients stands out in the field due to her discovery of new ways to generate probiotics that combat COVID-19 infection. Furthermore, her success here indicates that she has already made progress toward advancing her proposed endeavor.
• We established that her research in her area is significant because it identifies biomarkers and develops targeted novel therapeutics for cardiometabolic disorders.
• We noted that her work represents progress toward her larger goal of advancing the identification of biomarkers and the development of targeted novel therapeutics for cardiometabolic disorders and associated co-morbidities like diabetes and obesity.
• Moreover, she obtained two recommendation letters for her petition packet.
• Due to its clear national importance, her research has been supported by funding from the National Institutes of Health (NIH). This funding is reserved solely for research directed at advancing the national interest, including investigations that bolster the capability of the United States to prevent disease and enhance the nation’s economic well-being.

All of these factors, her education, experience, expertise, record of publication and citation, and history of successful research in the field, all indicate that she is well-positioned to advance the proposed endeavor. These facts aided by the excellent case preparation strategy employed by our experts, helped her obtain her NIW (National Interest Waiver) application approval. We are grateful to her for her continued trust in us. We wish her the very best in her life.